OncoEthix is a clinical stage biotechnology company developing innovative cancer drugs. OncoEthix SA was founded in 2007 to develop a portfolio of 3 to 5 promising new drugs for cancer treatment. The company intends to develop its compounds through clinical proof of concept and the identification of an expedited registration strategy, after which pharmaceutical partners will be sought to fund pivotal trials and handle commercialization.

In June 2012 OncoEthix in-licensed an anticancer compound from MTPC. OncoEthix product pipeline includes three first-in-class agents to novel cancer targets or with novel mode of action. Two of these agents are in clinical development.

Company Info
Country: Switzerland
Industry:    Biotech
Sector: biotechnology
Status: Realized
Vehicle: Endeavour II LP

Company website

Endeavour Vision Team
Sven Lingjaerde
Damien Tappy
© Endeavour Vision SA 2006-2017 Terms & Conditions